You are registered
Go to My Registration
PROGRAM OVERVIEW During 2021, hospitals were fined by the Drug Enforcement Administration for the improper handling and prescribing of controlled substances. Because of the opioid epidemic, hospitals have been added to the government’s continued focus on prescription opioids. This online seminar will discuss the DEA’s specific authorities in the practice of medicine and controlled substances and how they relate to hospitals and medical clinics. Through a review of federal law and case studies involving several hospital investigations, attendees will learn what triggers a DEA investigation, how to respond and how to prevent investigations from happening. The session also will cover updates about new federal pharmacy requirements for suspicious order monitoring, DEA registration, controlled substance security requirements and emerging best practice tips. LEARNING OBJECTIVES Describe the DEA’s specific authorities and role with controlled substances, hospitals and the practice of medicine. Discuss practical strategies and tips to reduce opioid risk at medical organizations while complying with federal law. Identify characteristics and red flags seen in hospitals that result in fines. INTENDED AUDIENCE C-suite. Clinical managers. Legal professionals Patient safety leaders. Regulatory managers. SPEAKER Dennis Wichern is a partner with Prescription Drug Consulting, where he focuses on risk mitigation and compliance initiatives to protect health care organizations and providers nationwide. Before this, he completed 30 years of public service as a DEA agent, last serving as the agent in charge of the Chicago field division. Wichern has been a guest lecturer about medical prescriber safeguards to medical students, residents and prescribers. He also has lectured with the American Bar Association health law section, the American Health Lawyers Association and the DEA Training Center. REGISTRATION AND FEES IHA organization member rate – $225 Associate org member rate – $225 IHA org nonmember rate – $300
PROGRAM OVERVIEW During 2021, hospitals were fined by the Drug Enforcement Administration for the improper handling and prescribing of controlled substances. Because of the opioid epidemic, hospitals have been added to the government’s continued focus on prescription opioids. This online seminar will discuss the DEA’s specific authorities in the practice of medicine and controlled substances and how they relate to hospitals and medical clinics. Through a review of federal law and case studies involving several hospital investigations, attendees will learn what triggers a DEA investigation, how to respond and how to prevent investigations from happening. The session also will cover updates about new federal pharmacy requirements for suspicious order monitoring, DEA registration, controlled substance security requirements and emerging best practice tips.
LEARNING OBJECTIVES Describe the DEA’s specific authorities and role with controlled substances, hospitals and the practice of medicine. Discuss practical strategies and tips to reduce opioid risk at medical organizations while complying with federal law. Identify characteristics and red flags seen in hospitals that result in fines.
INTENDED AUDIENCE
SPEAKER Dennis Wichern is a partner with Prescription Drug Consulting, where he focuses on risk mitigation and compliance initiatives to protect health care organizations and providers nationwide. Before this, he completed 30 years of public service as a DEA agent, last serving as the agent in charge of the Chicago field division. Wichern has been a guest lecturer about medical prescriber safeguards to medical students, residents and prescribers. He also has lectured with the American Bar Association health law section, the American Health Lawyers Association and the DEA Training Center.
REGISTRATION AND FEES IHA organization member rate – $225 Associate org member rate – $225 IHA org nonmember rate – $300